A common starting point may involve 25 mg taken twice daily, with adjustments based on appetite changes, tolerability, and overall progress
Additional testing may be indicated to include echocardiography, cardiac stress testing, electrocardiogram monitoring, or electrophysiologic studies to distinguish whether symptoms correlate with cardiac arrhythmia or structural or ischemic heart disease
The frequency of glutathione IV therapy depends on individual health needs and goals
Most studies have been short-term (812 weeks), involved small sample sizes, and used heterogeneous probiotic formulations, making it difficult to draw definitive conclusions about efficacy or to identify which specific strains might be beneficial
Gerriets VA, Kishton RJ, Nichols AG, Macintyre AN, Inoue M, Ilkayeva O, et al